“Antiproliferative effects of 13α/β-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ERα” (2023) Brazilian Journal of Pharmaceutical Sciences, 59, p. e22540. doi:10.1590/s2175-97902023e22540.